Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial import inner membrane translocase subunit Tim10 (TIMM10) is a small evolutionarily conserved protein that acts as a chaperone in the mitochondrial intermembrane space[3][4][5]. It is a core component of the TIM22 complex, which mediates the import and insertion of multi-pass transmembrane proteins, particularly metabolite carriers, into the inner mitochondrial membrane[1][3][4][5]. TIMM10 forms a heterooligomeric complex with other small Tim proteins (such as Tim9 and Tim12) and protects hydrophobic precursors from aggregation, ensuring their proper transfer and insertion. Dysfunction or mutation in TIMM10 impairs mitochondrial bioenergetics and can cause recessive disorders such as Mohr-Tranebjaerg syndrome, characterized by progressive neurodegeneration[3][5][7]. Key biological processes involving TIMM10 relate to mitochondrial integrity and metabolic competence, as it is indispensable for the assembly and maintenance of the mitochondrial inner membrane protein composition[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial import inner membrane translocase subunit Tim10 (TIMM10).